AltMountain

Remiges BioPharma Fund II, LP

Cambridge, MA · CIK 1779994
Status: no Form D since Jun 2019. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Remiges BioPharma Fund II, LP is a venture capital fund based in Cambridge, Massachusetts. Its most recent Form D, filed Jun 20, 2019, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Remiges BioPharma Fund GP II, Inc; Taro Inaba.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Remiges BioPharma Fund GP II, Inc; Taro Inaba
Latest Form D
Jun 20, 2019

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Jun 20, 2019Form D/A (amendment)$00SEC.gov ↗
Jun 19, 2019Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 19, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Remiges BioPharma Fund II, LP

What is the minimum investment for Remiges BioPharma Fund II, LP?

Remiges BioPharma Fund II, LP's latest Form D, filed Jun 20, 2019, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Remiges BioPharma Fund II, LP?

Remiges BioPharma Fund II, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has Remiges BioPharma Fund II, LP raised?

Remiges BioPharma Fund II, LP's latest Form D, filed Jun 20, 2019, reports no sales yet.

Where is Remiges BioPharma Fund II, LP based?

Remiges BioPharma Fund II, LP is based in Cambridge, Massachusetts.

Size compared with every venture capital fund

This fund hasn't reported any sales yet.

Other funds with the same team

More venture capital funds in Cambridge

Recently filed venture capital funds in Massachusetts

All venture capital funds in Massachusetts